Literature DB >> 23894

Detection and prevalence of pneumococci with increased resistance to penicillin.

J M Dixon, A E Lipinski, M E Graham.   

Abstract

Susceptibility to penicillin was determined for 6000 strains of pneumococci isolated during 1974--76 from patients in Alberta and the adjacent region of the Northwest Territories. Strains were considered to be relatively resistant if the minimum inhibitory concentration (MIC) of penicillin was 0.16 microgram (0.26 U)/mL or more, which is eight or more times greater than the MIC for fully susceptible strains. Resistance was detected in 143 strains (2.4%) isolated from 122 patients and belonging to four capsular types. The MIC of the most resistant strains was 0.32 microgram (0.53 U/mL. Penicillin-resistant strains were highly resistant to oxacillin, the MIC being at least 30 times greater than that for penicillin-susceptible strains. Pneumococci resistant to penicillin may readily be detected by the narrowness or absence of a zone of inhibition around a 1-microgram oxacillin disc in susceptibility tests on blood agar. The degree of resistance reported here is relative and does not necessarily preclude successful treatment with full therapeutic doses of penicillin G, but penicillin preparations that give low blood concentrations may not be suitable for treating infections caused by these strains.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 23894      PMCID: PMC1880287     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  13 in total

1.  Antibiotic sensitivity pattern of pneumococci relatively insensitive to penicillin and cephalosporin antibiotics.

Authors:  D Hansman
Journal:  Med J Aust       Date:  1975-11-08       Impact factor: 7.738

2.  Susceptibility of pneumococci to nine antibiotics.

Authors:  J W Kislak; L M Razavi; A K Daly; M Finland
Journal:  Am J Med Sci       Date:  1965-09       Impact factor: 2.378

3.  Increased resistance to penicillin of pneumococci isolated from man.

Authors:  D Hansman; H Glasgow; J Sturt; L Devitt; R Douglas
Journal:  N Engl J Med       Date:  1971-01-28       Impact factor: 91.245

4.  Prevalence of types of Diplococcus pneumoniae and their susceptibility to 30 antibiotics.

Authors:  J Cybulska; J Jeljaszewicz; E Lund; A Munksgaard
Journal:  Chemotherapy       Date:  1970       Impact factor: 2.544

5.  D. pneumoniae. Increased resistance to oxacillin and cloxacillin.

Authors:  T C Shope; P G Quie
Journal:  Minn Med       Date:  1968-01

6.  Pneumococci relatively insensitive to penicillin in Australia and New Guinea.

Authors:  D Hansman; L Devitt; H Miles; I Riley
Journal:  Med J Aust       Date:  1974-09-07       Impact factor: 7.738

7.  Distribution of the sensitivities to penicillin of types of Diplococcus pneumoniae in an American Indian population.

Authors:  B Tempest; J P Carney; B Eberle
Journal:  J Infect Dis       Date:  1974-07       Impact factor: 5.226

8.  Relapsing pneumococcal meningitis: isolation of an organism with decreased susceptibility to penicillin G.

Authors:  S Naraqi; G P Kirkpatrick; S Kabins
Journal:  J Pediatr       Date:  1974-11       Impact factor: 4.406

9.  Human infection caused by penicillin-insensitive pneumococci.

Authors:  L Devitt; I Riley; D Hansman
Journal:  Med J Aust       Date:  1977-04-16       Impact factor: 7.738

10.  Penicillin-resistant variants of pneumococci.

Authors:  J B Gunnison; M A Fraher; E A Pelcher; E Jasetz
Journal:  Appl Microbiol       Date:  1968-02
View more
  32 in total

1.  Activity of vancomycin, teicoplanin and cephalosporins against penicillin-susceptible and penicillin-intermediate Streptococcus pneumoniae.

Authors:  V G Loo; J Lavallée; D McAlear; H G Robson
Journal:  Can J Infect Dis       Date:  1995-03

2.  Emergence of a unique penicillin-resistant Streptococcus pneumoniae serogroup 35 strain.

Authors:  Ronald J Stanek; Mary B Maher; Nancy B Norton; Maurice A Mufson
Journal:  J Clin Microbiol       Date:  2010-10-27       Impact factor: 5.948

3.  Reduced susceptibility to penicillin among pneumococci causing invasive infection in children - Canada, 1991 to 1998.

Authors:  D Scheifele; S Halperin; L Pelletier; J Talbot; M Lovgren; W Vaudry; T Jadavji; B Law; N Macdonald; R Gold; E Wang; E Mills; M Lebel; P Déry; R Morris
Journal:  Can J Infect Dis       Date:  2001-07

4.  Determination of penicillin MICs for Streptococcus pneumoniae by using a two- or three-disk diffusion procedure.

Authors:  M R Jacobs; S Bajaksouzian; E L Palavecino-Fasola; H M Holoszyc; P C Appelbaum
Journal:  J Clin Microbiol       Date:  1998-01       Impact factor: 5.948

5.  Assessment of the oxacillin disk screening test for determining penicillin resistance in Streptococcus pneumoniae.

Authors:  G V Doern; A B Brueggemann; G Pierce
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-04       Impact factor: 3.267

6.  Screening pneumococci for penicillin resistance.

Authors:  J M Swenson; B C Hill; C Thornsberry
Journal:  J Clin Microbiol       Date:  1986-11       Impact factor: 5.948

7.  Pneumococci resistant to erythromycin.

Authors:  J M Dixon; A E Lipinski
Journal:  Can Med Assoc J       Date:  1978-11-04       Impact factor: 8.262

8.  Surveillance of invasive Streptococcus pneumoniae infection in the province of Quebec, Canada, from 1996 to 1998: serotype distribution, Antimicrobial susceptibility, and clinical characteristics.

Authors:  L P Jetté; G Delage; L Ringuette; R Allard; P De Wals ; F Lamothe; V Loo
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

9.  Surveillance of invasive Streptococcus pneumoniae infection in Quebec, Canada, from 1984 to 1986: serotype distribution, antimicrobial susceptibility, and clinical characteristics.

Authors:  L P Jetté; F Lamothe
Journal:  J Clin Microbiol       Date:  1989-01       Impact factor: 5.948

10.  Penicillin-binding components of penicillin-susceptible and -resistant strains of Streptococcus pneumoniae.

Authors:  P B Percheson; L E Bryan
Journal:  Antimicrob Agents Chemother       Date:  1980-09       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.